Published June 11, 2017 | Version v1

Structure-based design and synthesis of new PFKFB3 kinase inhibitors as candidate therapeutics for treating atherosclerosis

  • 1. University of Aberdeen
  • 2. University of Milan

Description

Abstract of the poster presentated at Medicinal Chemistry Residential School on 11 June 2017 at University of Loughborough

Files

Structure-based design and synthesis of new PFKFB3 kinase_Abstract_POSTER.pdf

Additional details

Funding

European Commission
MOGLYNET - Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study 675527